Special care is taken to help subjects understand the study so that they can be active participants in their treatment. To ensure safety for all subjects, every GCRC study must be reviewed and approved by the New York University Medical Center Institutional Review Board , the GCRC Executive Advisory Committee and Bellevue Hospital Research Review Committee. All information regarding clinical trials is kept confidential. Individuals participating in a study must meet certain requirements, such as physical condition, age, or stage of disease and must be willing to sign an informed consent. Consent must be given freely without undue influence.
Subjects have a right to withdraw from a study at any time without jeopardizing their medical care.
Enrolling in clinical trials offers patients the opportunity to participate in scientific cutting-edge treatment.